FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称OPNURASIB
异名/同义词1-(6-((4M)-4-(5-CHLORO-6-METHYL-1H-INDAZOL-4-YL)-5- METHYL-3-(1-METHYL-1H-INDAZOL-5-YL)-1H-PYRAZOL-1-YL)-2- AZASPIRO(3.3)HEPTAN-2-YL)PROP-2-EN-1-ONE
1-(6-((4M)-4-(5-CHLORO-6-METHYL-1H-INDAZOL-4-YL)-5-METHYL-3-(1-METHYL-1H-INDAZOL-5-YL)-1H-PYRAZOL-1-YL)-2-AZASPIRO(3.3)HEPTAN-2-YL)PROP-2-EN-1-ONE
1-(6-((4R)-4-(5-CHLORO-6-METHYL-1H-INDAZOL-4-YL)-5-METHYL-3-(1-METHYL-1H-INDAZOL-5-YL)-1H-PYRAZOL-1-YL)-2-AZASPIRO(3.3)HEPT-2-YL)-2-PROPEN-1-ONE
2-PROPEN-1-ONE, 1-(6-((4R)-4-(5-CHLORO-6-METHYL-1H-INDAZOL-4-YL)-5-METHYL-3-(1-METHYL-1H-INDAZOL-5-YL)-1H-PYRAZOL-1-YL)-2-AZASPIRO(3.3)HEPT-2-YL)-
JDQ443
JDQ-443
NVP-JDQ-443
OPNURASIB
OPNURASIB [INN]
OPNURASIB [USAN]
OPNURASIB [WHO-DD]
CAS登记号2653994-08-0
物质唯一标识(Unique Ingredient Identifier)Q3W0H3V1LQ
分子式C29H28ClN7O
国际化合物标识(International Chemical Identifier,InChI)AZUYLZMQTIKGSC-UHFFFAOYSA-N
SMILESn1n(C)c2ccc(cc2c1)-c3c(c(n(C4CC5(CN(C(C=C)=O)C5)C4)n3)C)-c6c(c(C)cc7c6cn[nH]7)Cl
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System